covid
Buscar en
Anales de Pediatría Continuada
Toda la web
Inicio Anales de Pediatría Continuada Inmunodeficiencias primarias. Enfoque y tratamiento iniciales
Información de la revista
Vol. 1. Núm. 3.
Páginas 131-138 (enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 1. Núm. 3.
Páginas 131-138 (enero 2003)
Acceso a texto completo
Inmunodeficiencias primarias. Enfoque y tratamiento iniciales
Visitas
85144
Jesús Ruiz Contreras
Sección de Lactantes e Inmunodeficiencias. Hospital Universitario 12 de Octubre. Madrid. España.
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Report of a WHO Scientific Group: primary immunodeficiency diseases.
Clin Exp Immunol, 109 (1997), pp. 1-28
[2.]
S. Smith, M.T. Sweetser, C.B. Wilson.
The immunocompromised host.
Pediatr Rev, 17 (1996), pp. 435-439
[3.]
J.M. Puck.
Primary immunodeficiency diseases.
Jama, 278 (1997), pp. 1835-1841
[4.]
F.S. Rosen, M.D. Cooper, R.J.P. Wedgwood.
The primary immunodeficiencies.
N Engl J Med, 333 (1995), pp. 431-440
[5.]
R.H. Buckley.
Primary immunodeficiency diseases due to defects in lymphocytes.
N Engl J Med, 343 (2000), pp. 1313-1324
[6.]
A. Fischer.
Primary immunodeficiency diseases: an experimental model for molecular medicine.
Lancet, 357 (2001), pp. 1863-1869
[7.]
S.H. Sicherer, J.A. Wilkelstein.
Primary immunodeficiency diseases in adults.
Jama, 279 (1998), pp. 58-61
[8.]
R.W. Hostofer.
Disorders of host defense.
Clinical management of infections in immunocompromised infants and children, pp. 3-32
[9.]
J.A. Lekstrom-Himes, J.I. Gallin.
Immunodeficiency diseases caused by defects in phagocytes.
N Engl J Med, 343 (2000), pp. 1703-1713
[10.]
R.B. Johnston.
Clinical aspects of chronic granulomatous disease.
Curr Opin Hematol, 8 (2001), pp. 17-22
[11.]
B.H. Segal, E.S. De Carlo, K.J. Kwon-Chung, H.L. Malech, J.L. Gallin, S.M. Holland.
Aspergillus nidulans infection in chronic granulomatous disease.
Medicine, 77 (1998), pp. 345-354
[12.]
B. Styrt.
Risk of infection and protective strategies for the asplenic patient.
Infect Dis Clin Pract, 5 (1996), pp. 94-100
[13.]
Working party of the British Commitee for Standars in Haematology Clinical Haematology Task Force.
Guidelines for the prevention and treatment in patients with absent or dysfuncional spleen.
B Med J, 312 (1996), pp. 430-434
[14.]
J.L. Stephan, V. Vlekova, F. Le Deist, S. Blanche, J. Donadieu, G. De Saint-Basile, et al.
Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patients.
J Pediatr, 123 (1993), pp. 564-572
[15.]
R.H. Buckley, R.I. Schiff, S.E. Schiff, L. Market, L.W. Williams, T.O. Harville, et al.
Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants.
J Pediatr, 130 (1997), pp. 378-387
[16.]
R.H. Buckley, S.E. Schiff, R.I. Schiff, M.L. Markert, L.W. Williams, J.L. Roberts, et al.
Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
N Engl J Med, 340 (1999), pp. 508-516
[17.]
J.A. Winkelstein, M.C. Marino, R.B. Johnston, J. Boyle, J. Curnutte, J.I. Gallin, et al.
Chronic granulomatous disease: report on a national registry of 368 patients.
Medicine, 79 (2000), pp. 155-169
[18.]
G. Marx, E.G. Seidman.
Gastrointestinal manifestations of primary immunodeficiencies.
Curr Op Gastroenterol, 17 (2001), pp. 551-554
[19.]
A. Eztioni.
Immune deficiency and autoimmunity [en prensa].
Autoimmun Rev, (2003),
[20.]
S.H. Schurman, F. Candotti.
Autoimmunity in Wiskott- Aldrichl sindrome.
Curr Opin Rheumatol, 15 (2003), pp. 446-453
[21.]
S. Sallah, J.Y. Wan, L.R. Hanrahan.
Future development of lymphoprolifetaive disordes in patients with autoimmune hemolytic anemia.
Clin Cancer Res, 7 (2001), pp. 791-794
[22.]
C. Cunningham-rundles, C. Bodian.
Common variable immunodeficiency: clinical and immunological features of 248 patients.
Clin Immunol, 92 (1999), pp. 34-48
[23.]
L.M. Noroski, W.T. Shearer.
Screening for primary immunodeficiencies in the clinica laboratory.
Clin Immunol Immunopathol, 86 (1998), pp. 237-245
[24.]
D.H. Margolis, D.A. Minick, D.W. Anlling, J.L. Gallin.
Trimethoprim- sulfametoxazole prophylaxis in the management of chronic granulomatous disease.
J Infect Dis, 162 (1990), pp. 723-726
[25.]
J.I. Gallin, D.W. Allin, H.L. Malech, R. Wesley, D. Koziol, B. Marciano, et al.
Itraconazole to prevent fungal infections in chronic granulomatous disease.
N Engl J Med, 248 (2003), pp. 2416-2422
[26.]
Comité Asesor de Vacunas de la AEP.
Vacunaciones en situaciones especiales. Inmunodeficiencias primarias. Manual de Vacunas en Pediatria.
Edicion, (2001), pp. 424-425
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos